Generate Biomedicines Inc
GENB
NASDAQ
Biotechnology
$15.64
USD
+0.61 (+4.06%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.89B
Volume 306.0K
Revenue
—
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
—
TTM
— YoY
Operating Cash Flow
—
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2026 | Q2 2026 |
|---|---|---|
Revenue | 7.2 | 6.3 |
YoY Growth | — | — |
Cost of Revenue | 0.0 | 0.0 |
Gross Profit | 7.2 | 6.3 |
Selling, General & Administrative | 13.5 | 13.6 |
Other Operating Expenses | 0.0 | 0.0 |
Total Operating Expenses | 71.3 | 77.9 |
Operating Income | -64.1 | -71.6 |
EBITDA | -60.8 | -68.4 |
Other Income / Expense | -0.3 | -0.1 |
Total Other Income / Expense | 2.4 | 4.4 |
Income Before Income Taxes | -61.7 | -67.2 |
Income Taxes | 0.0 | 0.1 |
Net Income | -61.7 | -67.3 |
Consolidated Net Income / Loss | -61.7 | -67.3 |
Net Income Attributable to Common Shareholders | -69.2 | -67.3 |
Basic EPS | -$1.07 | -$0.52 |
Diluted EPS | -$1.07 | -$0.52 |
Basic Shares Outstanding | 64.9M | 128.2M |
Diluted Shares Outstanding | 64.9M | 128.2M |